MTB
65
2
AMG
52
2
PVH
57
5
EFX
36
4
SWKS
49
11
SO
57
2
CB
51
3
SBUX
39
3
PM
64
2
URI
60
7
GWW
71
4
COST
63
5
ROK
47
-8
APH
67
3
K
57
4
MLM
51
3
AIG
44
6
DHR
38
3
IVZ
48
2
DTE
54
4
MTB
65
2
AMG
52
2
PVH
57
5
EFX
36
4
SWKS
49
11
SO
57
2
CB
51
3
SBUX
39
3
PM
64
2
URI
60
7
GWW
71
4
COST
63
5
ROK
47
-8
APH
67
3
K
57
4
MLM
51
3
AIG
44
6
DHR
38
3
IVZ
48
2
DTE
54
4
Financhill
Back

Cytokinetics Vs. Ocugen Industry Stock Comparison

Sell
37

CYTK
Cytokinetics

Last Price:
47.66
Seasonality Move:
14.49%
Sell
42

OCGN
Ocugen

Last Price:
0.90
Seasonality Move:
357.24%
Sell
37
Cytokinetics (CYTK) is a Sell

Is Cytokinetics a Buy, Sell or Hold?

  • The current Cytokinetics [CYTK] share price is $47.67. The Score for CYTK is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • CYTK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Ocugen (OCGN) is a Sell

Is Ocugen a Buy, Sell or Hold?

  • The current Ocugen [OCGN] share price is $0.90. The Score for OCGN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • OCGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CYTK Stock Price Chart

What is Cytokinetics's stock price today?

  • The Cytokinetics share price today is $47.67
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing selling pressure, which indicates risk of future bearish movement.

OCGN Stock Price Chart

What is Ocugen's stock price today?

  • The Ocugen share price today is $0.90
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OCGN is experiencing selling pressure, which indicates risk of future bearish movement.

CYTK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.92 Sell
Relative Strength Index (14 RSI): 34.51 Sell
Chaikin Money Flow: -1683871 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.53 - 55.71) Sell
Bollinger Bands (100): (52.65 - 57.25) Sell

OCGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 43.91 Sell
Chaikin Money Flow: -1716624 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.9 - 1) Sell
Bollinger Bands (100): (0.93 - 1.51) Sell

CYTK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 52.2 Sell
20-day SMA: 52.95 Sell
50-day SMA: 53.73 Sell
200-day SMA: 59.65 Sell
8-day EMA: 51.38 Sell
20-day EMA: 52.78 Sell
50-day EMA: 53.72 Sell
200-day EMA: 55.37 Sell

OCGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.94 Sell
20-day SMA: 0.96 Sell
50-day SMA: 0.99 Sell
200-day SMA: 1.29 Sell
8-day EMA: 0.93 Sell
20-day EMA: 0.95 Sell
50-day EMA: 1.02 Sell
200-day EMA: 1.14 Sell

Cytokinetics Earnings Growth & CYTK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.35 per share, and an increase next year of $0.07 per share.

Ocugen Earnings Growth & OCGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.07 per share.

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ocugen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):